▶ 調査レポート

世界の自動ペプチド合成装置市場予測(~2028年):シングルチャンネル、マルチチャンネル

• 英文タイトル:Global Automated Peptide Synthesizer Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の自動ペプチド合成装置市場予測(~2028年):シングルチャンネル、マルチチャンネル / Global Automated Peptide Synthesizer Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 / GIR-22F10131資料のイメージです。• レポートコード:GIR-22F10131
• 出版社/出版日:GlobalInfoResearch / 2022年11月
• レポート形態:英文、PDF、107ページ
• 納品方法:Eメール(2~3営業日)
• 産業分類:産業機器
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
「Global Automated Peptide Synthesizer Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
グローバルインフォリサーチ社の最新の調査によると、世界の自動ペプチド合成装置の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。

自動ペプチド合成装置市場はタイプ(種類)とアプリケーション(用途)によって区分されます。2017年~2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・シングルチャンネル、マルチチャンネル

アプリケーション別セグメントは次のように区分されます。
・学校研究室、バイオ医薬品企業、合成サービス企業

世界の自動ペプチド合成装置市場の主要な市場プレーヤーは以下のとおりです。
・Gyros Protein Technologies AB、Büchi AG、Biotage、CEM、CSBio、AAPPTec、Activotec、MultiSynTech、NJ Biopharmaceuticals LLC、Peptide Machines, Inc.、Protein Technologies, Inc.、Intavis AG、HAINAN JIANBANG PHARMACEUTICAL

地域別セグメントは次の地域・国をカバーします。
・北米市場(米国、カナダ、メキシコ)
・ヨーロッパ市場(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋市場(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南米市場(ブラジル、アルゼンチン、コロンビア)
・中東・アフリカ市場(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、自動ペプチド合成装置製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な自動ペプチド合成装置メーカーの企業概要、2019年~2022年までの自動ペプチド合成装置の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な自動ペプチド合成装置メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年~2028年までの地域別自動ペプチド合成装置の販売量、売上、成長性を示しています。
・第5、6章では、2017年~2028年までの自動ペプチド合成装置のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域での自動ペプチド合成装置市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および自動ペプチド合成装置の産業チェーンを掲載しています。
・第13、14、15章では、自動ペプチド合成装置の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 自動ペプチド合成装置の概要
- タイプ別分析(2017年vs2021年vs2028年):シングルチャンネル、マルチチャンネル
- アプリケーション別分析(2017年vs2021年vs2028年):学校研究室、バイオ医薬品企業、合成サービス企業
- 世界の自動ペプチド合成装置市場規模・予測
- 世界の自動ペプチド合成装置生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
- Gyros Protein Technologies AB、Büchi AG、Biotage、CEM、CSBio、AAPPTec、Activotec、MultiSynTech、NJ Biopharmaceuticals LLC、Peptide Machines, Inc.、Protein Technologies, Inc.、Intavis AG、HAINAN JIANBANG PHARMACEUTICAL
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・タイプ別分析2017年-2028年:シングルチャンネル、マルチチャンネル
・アプリケーション別分析2017年-2028年:学校研究室、バイオ医薬品企業、合成サービス企業
・自動ペプチド合成装置の北米市場分析
- 自動ペプチド合成装置の北米市場:タイプ別市場規模2017年-2028年
- 自動ペプチド合成装置の北米市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:アメリカ、カナダ、メキシコなど
・自動ペプチド合成装置のヨーロッパ市場分析
- :自動ペプチド合成装置のヨーロッパ市場:タイプ別市場規模2017年-2028年
- :自動ペプチド合成装置のヨーロッパ市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・自動ペプチド合成装置のアジア太平洋市場分析
- 自動ペプチド合成装置のアジア太平洋市場:タイプ別市場規模2017年-2028年
- 自動ペプチド合成装置のアジア太平洋市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・自動ペプチド合成装置の南米市場分析
- 自動ペプチド合成装置の南米市場:タイプ別市場規模2017年-2028年
- 自動ペプチド合成装置の南米市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:ブラジル、アルゼンチンなど
・自動ペプチド合成装置の中東・アフリカ市場分析
- 自動ペプチド合成装置の中東・アフリカ市場:タイプ別市場規模2017年-2028年
- 自動ペプチド合成装置の中東・アフリカ市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Automated Peptide Synthesizer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Automated Peptide Synthesizer market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. School Laboratory accounting for % of the Automated Peptide Synthesizer global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Single Channel segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Automated Peptide Synthesizer include Gyros Protein Technologies AB, Büchi AG, Biotage, CEM, and CSBio, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Automated Peptide Synthesizer market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Single Channel
Multi-channel
Market segment by Application can be divided into
School Laboratory
Biopharmaceutical Company
Synthesis Services Company
The key market players for global Automated Peptide Synthesizer market are listed below:
Gyros Protein Technologies AB
Büchi AG
Biotage
CEM
CSBio
AAPPTec
Activotec
MultiSynTech
NJ Biopharmaceuticals LLC
Peptide Machines, Inc.
Protein Technologies, Inc.
Intavis AG
HAINAN JIANBANG PHARMACEUTICAL
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Automated Peptide Synthesizer product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Automated Peptide Synthesizer, with price, sales, revenue and global market share of Automated Peptide Synthesizer from 2019 to 2022.
Chapter 3, the Automated Peptide Synthesizer competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Automated Peptide Synthesizer breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Automated Peptide Synthesizer market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Automated Peptide Synthesizer.
Chapter 13, 14, and 15, to describe Automated Peptide Synthesizer sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Automated Peptide Synthesizer Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Automated Peptide Synthesizer Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Single Channel
1.2.3 Multi-channel
1.3 Market Analysis by Application
1.3.1 Overview: Global Automated Peptide Synthesizer Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 School Laboratory
1.3.3 Biopharmaceutical Company
1.3.4 Synthesis Services Company
1.4 Global Automated Peptide Synthesizer Market Size & Forecast
1.4.1 Global Automated Peptide Synthesizer Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Automated Peptide Synthesizer Sales in Volume (2017-2028)
1.4.3 Global Automated Peptide Synthesizer Price (2017-2028)
1.5 Global Automated Peptide Synthesizer Production Capacity Analysis
1.5.1 Global Automated Peptide Synthesizer Total Production Capacity (2017-2028)
1.5.2 Global Automated Peptide Synthesizer Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Automated Peptide Synthesizer Market Drivers
1.6.2 Automated Peptide Synthesizer Market Restraints
1.6.3 Automated Peptide Synthesizer Trends Analysis
2 Manufacturers Profiles
2.1 Gyros Protein Technologies AB
2.1.1 Gyros Protein Technologies AB Details
2.1.2 Gyros Protein Technologies AB Major Business
2.1.3 Gyros Protein Technologies AB Automated Peptide Synthesizer Product and Services
2.1.4 Gyros Protein Technologies AB Automated Peptide Synthesizer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Büchi AG
2.2.1 Büchi AG Details
2.2.2 Büchi AG Major Business
2.2.3 Büchi AG Automated Peptide Synthesizer Product and Services
2.2.4 Büchi AG Automated Peptide Synthesizer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Biotage
2.3.1 Biotage Details
2.3.2 Biotage Major Business
2.3.3 Biotage Automated Peptide Synthesizer Product and Services
2.3.4 Biotage Automated Peptide Synthesizer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 CEM
2.4.1 CEM Details
2.4.2 CEM Major Business
2.4.3 CEM Automated Peptide Synthesizer Product and Services
2.4.4 CEM Automated Peptide Synthesizer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 CSBio
2.5.1 CSBio Details
2.5.2 CSBio Major Business
2.5.3 CSBio Automated Peptide Synthesizer Product and Services
2.5.4 CSBio Automated Peptide Synthesizer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 AAPPTec
2.6.1 AAPPTec Details
2.6.2 AAPPTec Major Business
2.6.3 AAPPTec Automated Peptide Synthesizer Product and Services
2.6.4 AAPPTec Automated Peptide Synthesizer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Activotec
2.7.1 Activotec Details
2.7.2 Activotec Major Business
2.7.3 Activotec Automated Peptide Synthesizer Product and Services
2.7.4 Activotec Automated Peptide Synthesizer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 MultiSynTech
2.8.1 MultiSynTech Details
2.8.2 MultiSynTech Major Business
2.8.3 MultiSynTech Automated Peptide Synthesizer Product and Services
2.8.4 MultiSynTech Automated Peptide Synthesizer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 NJ Biopharmaceuticals LLC
2.9.1 NJ Biopharmaceuticals LLC Details
2.9.2 NJ Biopharmaceuticals LLC Major Business
2.9.3 NJ Biopharmaceuticals LLC Automated Peptide Synthesizer Product and Services
2.9.4 NJ Biopharmaceuticals LLC Automated Peptide Synthesizer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Peptide Machines, Inc.
2.10.1 Peptide Machines, Inc. Details
2.10.2 Peptide Machines, Inc. Major Business
2.10.3 Peptide Machines, Inc. Automated Peptide Synthesizer Product and Services
2.10.4 Peptide Machines, Inc. Automated Peptide Synthesizer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Protein Technologies, Inc.
2.11.1 Protein Technologies, Inc. Details
2.11.2 Protein Technologies, Inc. Major Business
2.11.3 Protein Technologies, Inc. Automated Peptide Synthesizer Product and Services
2.11.4 Protein Technologies, Inc. Automated Peptide Synthesizer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Intavis AG
2.12.1 Intavis AG Details
2.12.2 Intavis AG Major Business
2.12.3 Intavis AG Automated Peptide Synthesizer Product and Services
2.12.4 Intavis AG Automated Peptide Synthesizer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 HAINAN JIANBANG PHARMACEUTICAL
2.13.1 HAINAN JIANBANG PHARMACEUTICAL Details
2.13.2 HAINAN JIANBANG PHARMACEUTICAL Major Business
2.13.3 HAINAN JIANBANG PHARMACEUTICAL Automated Peptide Synthesizer Product and Services
2.13.4 HAINAN JIANBANG PHARMACEUTICAL Automated Peptide Synthesizer Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Automated Peptide Synthesizer Breakdown Data by Manufacturer
3.1 Global Automated Peptide Synthesizer Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Automated Peptide Synthesizer Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Automated Peptide Synthesizer
3.4 Market Concentration Rate
3.4.1 Top 3 Automated Peptide Synthesizer Manufacturer Market Share in 2021
3.4.2 Top 6 Automated Peptide Synthesizer Manufacturer Market Share in 2021
3.5 Global Automated Peptide Synthesizer Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Automated Peptide Synthesizer Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Automated Peptide Synthesizer Market Size by Region
4.1.1 Global Automated Peptide Synthesizer Sales in Volume by Region (2017-2028)
4.1.2 Global Automated Peptide Synthesizer Revenue by Region (2017-2028)
4.2 North America Automated Peptide Synthesizer Revenue (2017-2028)
4.3 Europe Automated Peptide Synthesizer Revenue (2017-2028)
4.4 Asia-Pacific Automated Peptide Synthesizer Revenue (2017-2028)
4.5 South America Automated Peptide Synthesizer Revenue (2017-2028)
4.6 Middle East and Africa Automated Peptide Synthesizer Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Automated Peptide Synthesizer Sales in Volume by Type (2017-2028)
5.2 Global Automated Peptide Synthesizer Revenue by Type (2017-2028)
5.3 Global Automated Peptide Synthesizer Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Automated Peptide Synthesizer Sales in Volume by Application (2017-2028)
6.2 Global Automated Peptide Synthesizer Revenue by Application (2017-2028)
6.3 Global Automated Peptide Synthesizer Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Automated Peptide Synthesizer Sales by Type (2017-2028)
7.2 North America Automated Peptide Synthesizer Sales by Application (2017-2028)
7.3 North America Automated Peptide Synthesizer Market Size by Country
7.3.1 North America Automated Peptide Synthesizer Sales in Volume by Country (2017-2028)
7.3.2 North America Automated Peptide Synthesizer Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Automated Peptide Synthesizer Sales by Type (2017-2028)
8.2 Europe Automated Peptide Synthesizer Sales by Application (2017-2028)
8.3 Europe Automated Peptide Synthesizer Market Size by Country
8.3.1 Europe Automated Peptide Synthesizer Sales in Volume by Country (2017-2028)
8.3.2 Europe Automated Peptide Synthesizer Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Automated Peptide Synthesizer Sales by Type (2017-2028)
9.2 Asia-Pacific Automated Peptide Synthesizer Sales by Application (2017-2028)
9.3 Asia-Pacific Automated Peptide Synthesizer Market Size by Region
9.3.1 Asia-Pacific Automated Peptide Synthesizer Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Automated Peptide Synthesizer Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Automated Peptide Synthesizer Sales by Type (2017-2028)
10.2 South America Automated Peptide Synthesizer Sales by Application (2017-2028)
10.3 South America Automated Peptide Synthesizer Market Size by Country
10.3.1 South America Automated Peptide Synthesizer Sales in Volume by Country (2017-2028)
10.3.2 South America Automated Peptide Synthesizer Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Automated Peptide Synthesizer Sales by Type (2017-2028)
11.2 Middle East & Africa Automated Peptide Synthesizer Sales by Application (2017-2028)
11.3 Middle East & Africa Automated Peptide Synthesizer Market Size by Country
11.3.1 Middle East & Africa Automated Peptide Synthesizer Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Automated Peptide Synthesizer Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Automated Peptide Synthesizer and Key Manufacturers
12.2 Manufacturing Costs Percentage of Automated Peptide Synthesizer
12.3 Automated Peptide Synthesizer Production Process
12.4 Automated Peptide Synthesizer Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Automated Peptide Synthesizer Typical Distributors
13.3 Automated Peptide Synthesizer Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer